Cohen Lawrence B Bristol Myers Squibb CO Transaction History

Cohen Lawrence B

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $631,557 - $701,245	-9,913 Reduced 29.88%	23,260 $1.49 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $77,800 - $88,243	1,184 Added 3.7%	33,173 $2.3 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $194,209 - $229,971	2,836 Added 9.73%	31,989 $2.3 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $2,510 - $1.48 Million	19,312 Added 196.24%	29,153 $2.07 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $988 - $584,445	-7,606 Reduced 43.59%	9,841 $719,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $552,347 - $608,327	7,606 Added 77.29%	17,447 $1.34 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $605,024 - $725,478	9,841 New	9,841 $719,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $217,308 - $253,331	-4,052 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $52,365 - $61,339	-885 Reduced 17.93%	4,052 $240,000
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $9,613 - $10,811	-162 Reduced 3.18%	4,937 $312,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $3,579 - $4,056	62 Added 1.23%	5,099 $316,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $5,857 - $6,491	-102 Reduced 1.98%	5,037 $304,000
Q2 2020 Jul 23, 2020	BUY	$54.82 - $64.09 $109 - $128	2 Added 0.04%	5,139 $302,000
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $238,356 - $346,387	5,137 New	5,137 $286,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

Stay updated on Cohen Lawrence B with notifications on news.